Kalsitriol: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
dev |
dev |
||
Baris 34:
| accessdate = 2010-12-10
| work = Core Genotyping Facility at the Advanced Technology Center of the National Cancer Institute, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Department of Health and Human Services, International Agency for Research on Cancer, Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Institute of Public Health, Institute of Carcinogenesis, Cancer Research Centre, Department of Preventive Medicine, Faculty of Medicine, Palacky University, Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University, Department of Epidemiology, Institute of Occupational Medicine, Ohio State University Medical Center; Sara Karami, Paul Brennan, Philip S. Rosenberg, Marie Navratilova, Dana Mates, David Zaridze, Vladimir Janout, Helena Kollarova, Vladimir Bencko, Vsevolod Matveev, Neonila Szeszenia-Dabrowska, Ivana Holcatova, Meredith Yeager, Stephen Chanock, Idan Menashe, Nathaniel Rothman, Wong-Ho Chow, Paolo Boffetta, dan Lee E. Moore
}}</ref> yang memiliki sifat anti-[[proliferasi|proliferatif]], pro-[[apoptosis|apoptotik]] dan pro-[[diferensiasi]] terhadap berbagai jenis [[sel (biologi)|sel]] [[tubuh]], dan sifat anti-[[kanker]], seperti [[kanker prostat]]
| url = http://www.ncbi.nlm.nih.gov/pubmed/14696037
| title = The pleiotropic actions of vitamin D
| accessdate = 2010-12-10
| work = Department of Physiology, McGill University; Lin R, White JH.
}}</ref> [[kanker indung telur]], [[kanker payudara]], [[leukimia]],<ref>{{en}}{{cite web
| url = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583388
| title = Vitamin D and Human Health: Lessons from Vitamin D Receptor Null Mice
| accessdate = 2010-12-10
| work = Katholieke Universiteit Leuven, Laboratory of Experimental Medicine and Endocrinology, Massachusetts General Hospital, Endocrine Unit; Roger Bouillon, Geert Carmeliet, Lieve Verlinden, Evelyne van Etten, Annemieke Verstuyf, Hilary F. Luderer, Liesbet Lieben, Chantal Mathieu, dan Marie Demay
| quote = To gain more insight into the antiproliferative and prodifferentiating effect of 1,25-(OH)2D, genomic profiling has been performed in malignant cells such as prostate (127,128,129,130,131,132,133), breast (134,135,136), leukemia (137,138), colon (139), and ovarian cancer (140) cells, and squamous cell carcinoma cells (141). Since then, the antineoplastic activity of 1,25-(OH)2D was shown both in vitro and in vivo in a wide variety of malignancies, such as leukemia (266,267) and colon (268,269), breast (270,271,272), and prostate cancer (273,274).
}}</ref> oleh kapasitas regulasi terhadap [[metabolisme]] [[kalsium]] dan [[ortofosfat|fosfat]],<ref>{{en}}{{cite web
| url = http://www.ncbi.nlm.nih.gov/pubmed/15970529
| |||